Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?
Research output: Contribution to journal › Journal article › Research › peer-review
The oncogenic potential of deregulated Notch signalling has been described in several haematopoietic malignancies. We have previously reported an increased expression of Notch1 in primary cutaneous CD30+ lymphoproliferative disorders, lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma (pcALCL).
|Journal||British Journal of Dermatology|
|Number of pages||8|
|Publication status||Published - 1 Oct 2010|